DC
PETX

Deere & Company’s Aratana Therapeutics, Inc. PETX Stock Holding History

Deere & Company’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-63,980
Closed -$599K – 893
2016
Q3 		$599K Hold
63,980
– – 0.03% 537
2016
Q2 		$404K Buy
+63,980
New +$411K 0.02% 750

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's PETX Position: Q4 2016 in Review

Deere & Company sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 63,980 shares — an estimated $599K sold.

Deere & Company first reported a position in PETX in Q2 2016 and held it in 2 quarters. The position peaked at $599K in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • Deere & Company reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 63,980 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $599K.
  • Deere & Company first reported a position in Aratana Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Deere & Company's Aratana Therapeutics, Inc. position peaked at $599K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.